Alice Chen specializes in health economics and labor economics. Professor Chen has expertise in a range of issues involving healthcare and pharmaceutical firms, including pharmaceutical competition and innovation, healthcare labor markets, and provider payment models.
Professor Chen has served as a consulting damages expert on life sciences matters, estimating the impact of allegedly false pharmaceutical marketing on prescription drug sales. In healthcare matters, she has offered written and deposition testimony on health insurance plan design in relation to class certification. She has testified at trial on statistical analyses of clinical trial data and regulatory drug approval. Professor Chen has also provided healthcare consulting services to pharmaceutical companies, including analyses of drug clinical trial data.
Professor Chen’s research has focused on improving the efficiency of healthcare markets, biologics and biosimilars innovation and competition, and the drivers and impacts of healthcare provider behavior. Her recent research analyzes the impact of Medicare policies on provider treatment decisions and healthcare outcomes and potential impacts of the Inflation Reduction Act on drug competition, pricing, and innovation. Professor Chen has presented her work before regulators at the Federal Trade Commission and the Congressional Budget Office.
Professor Chen has published articles in leading economics, health policy, and medical journals, including the American Economic Journal: Economic Policy, Health Affairs, JAMA Internal Medicine, and the Journal of Health Economics. Her research has also been cited in major media outlets, including Bloomberg, CBS News, Forbes, the New York Times, and the Washington Post.
At USC Price, Professor Chen teaches undergraduate- and graduate-level courses in health economics and health finance. The USC Health Administration Graduate Program has recognized her as Outstanding Faculty of the Year.
|
|